In Depth 15 Jan 2024
The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
Stem cells
- Latest Posts
News and Trends 12 Jan 2024
AI and a brain organoid: can this combo take on supercomputers?
Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer.
Podcast 10 Nov 2023
How biotech can mend a broken heart
CellProthera has been working to do the impossible – mend broken hearts. The biotech company’s ProtheraCytes cell therapy regenerates damaged tissue following a heart attack, thus restoring cardiac function. In this podcast, we investigate regenerative therapy with CellProthera’s CEO, Matthieu de Kalbermatten. While regenerative cell therapy is dependent on the patient’s own cells, and reliant […]
Podcast 20 Oct 2023
Beyond Biotech podcast 68 – rejuvenation with stem cells
This week, our guest on the podcast is Mark Kotter, founder of clock.bio. clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells […]
Best in Biotech 30 Aug 2023
Five North Carolina biotech companies making their mark
North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs in the U.S., with a multitude of renowned companies. The southeastern state even rivals the likes of Boston, San Francisco, Los Angeles, and San Diego, […]
In Depth 22 Aug 2023
Lab-grown babies on the horizon: how IVG could transform human reproduction
Lately, there seems to have been a lot of talk about the possibility of ‘lab-grown babies’. Proper research into this area kicked off around a decade ago, and is still largely experimental in humans. But the technique used to potentially develop lab-grown babies could hold the power to provide a novel treatment option for human […]
ADVERTISEMENT
ADVERTISEMENT
In Depth 15 Aug 2023
Can stem cell treatment repair damaged knees?
Scientists’ fascination with amphibians like axolotls and newts, animals that are capable of scarlessly regrowing their limbs, sparked the idea of possibly replicating this in humans. Since 1958, when French oncologist Georges Mathe performed the first-ever stem cell transplantation – to save six nuclear researchers who were accidentally exposed to radiation – the technology has […]
News and Trends 13 Jun 2023
‘Clinical trial in a dish’ for Alzheimer’s disease
Axol Bioscience Ltd., a pluripotent stem cell technology provider for drug discovery, has signed an agreement with StrataStem to access and commercialize its collection of Alzheimer’s disease (AD) patient samples. Harnessing its stem cell knowledge, Axol will reprogram these patient samples into induced pluripotent stem cells (iPSCs) that can then be differentiated into a wide […]
News and Trends 9 May 2023
Researchers overcome stem cell delivery issues
A recent study explains how researchers have devised a new method for delivering particles into stem cells, which are difficult to penetrate. The discovery will make it easier to direct and enhance the processes involved in regenerative medicine. Regenerative medicine takes advantage of the fact that our body’s stem cells can change into many other […]
Becoming human: GMP-compliant supplements for cell therapy
News and Trends 24 Mar 2023
Metabolism of RNA linked to leukemia
Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids, RNA, to the development of leukemia in myelodysplastic syndrome patients, MDS. In a study published in the Molecular Cell journal, they explain what makes hematopoietic stem cells acquire malignant traits in cancer. RNA splicing is […]
News and Trends 7 Feb 2023
Endogena Therapeutics retinitis pigmentosa treatment gets FDA fast track designation
The US Food and Drug Administration (FDA) has designated the investigation of Endogena Therapeutics’ EA-2353 for the treatment of retinitis pigmentosa (RP) as a fast track development program. Fast track is a process designed to enable patients to benefit earlier from new drugs for serious conditions. Endogena Therapeutics’ EA-2353 takes a novel, small-molecule approach and […]
ADVERTISEMENT
